GridAI Technologies Corp. (ENTO) reports stock changes
- Sawyer Jason David acquired 250,000 shares on 09/30/2026
- Sawyer now holds 790,000 shares directly
- Sawyer is Chief Executive Officer of GridAI
Jason David Sawyer, reporting
ENTO
GridAI Technologies Corp. SEC filings
Every EDGAR filing for GridAI Technologies Corp. (ENTO), newest first, with AI summaries and stories.
- Ticker
- ENTO
- CIK
- 1604191
- Sector
- Utilities
- Latest filing
- Oct 9
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE4GridAI Technologies Corp.ENTOLIVE ROUTINE8-KGridAI Technologies Corp.ENTOLIVE GridAI Technologies Corp. (ENTO) reports loan extensions.
- Loan to Pronghorn Resources, LLC increased to $3.5M.
- Second Amended Note dated October 1, 2026.
- Security agreement amended on October 1, 2026.
ROUTINES-1/AGridAI Technologies Corp.ENTOLIVE GridAI Technologies Corp. files S-1/A
- Filed S-1/A on 2026-10-06
- Registered 9,908,766 shares of common stock
- Includes shares from May and July 2026 private placements
ROUTINE8-KGridAI Technologies Corp.ENTOLIVE ROUTINES-1/AGridAI Technologies Corp.ENTOLIVE NOTABLE10-QGridAI Technologies Corp.ENTOLIVE NOTABLENT 10-QGridAI Technologies Corp.ENTOLIVE ROUTINES-1/AGridAI Technologies Corp.ENTOLIVE ROUTINE8-KGridAI Technologies Corp.ENTOLIVE ROUTINEDGridAI Technologies Corp.ENTOLIVE ROUTINES-1/AGridAI Technologies Corp.ENTOLIVE NOTABLESCHEDULE 13DGridAI Technologies Corp.ENTOLIVE Ownership stake disclosure by Jason David Sawyer
Jason David Sawyer, filed by
ROUTINE8-K/AGridAI Technologies Corp.ENTOLIVE ROUTINE8-KGridAI Technologies Corp.ENTOLIVE ROUTINE4GridAI Technologies Corp.ENTOLIVE Jason David Sawyer, insider filing for ENTO
Jason David Sawyer, reporting
ROUTINEPOS AMGridAI Technologies Corp.ENTOLIVE ROUTINE4GridAI Technologies Corp.ENTOLIVE Jack Syage, insider filing for ENTO
Jack Syage, reporting
NOTABLE10-QGridAI Technologies Corp.ENTOLIVE ROUTINE8-KGridAI Technologies Corp.ENTOLIVE NOTABLENT 10-QGridAI Technologies Corp.ENTOLIVE ROUTINE8-KGridAI Technologies Corp.ENTOLIVE ROUTINE8-KGridAI Technologies Corp.ENTOLIVE NOTABLE10-KGridAI Technologies Corp.ENTOLIVE ROUTINE8-KGridAI Technologies Corp.ENTOLIVE ROUTINE8-KGridAI Technologies Corp.ENTOLIVE ROUTINE8-K/AGridAI Technologies Corp.ENTOLIVE NOTABLENT 10-KGridAI Technologies Corp.ENTOLIVE ROUTINESCHEDULE 13G/AGridAI Technologies Corp.ENTOLIVE Ownership stake disclosure by RENAISSANCE TECHNOLOGIES LLC (amended)
RENAISSANCE TECHNOLOGIES LLC, filed by
ROUTINESCHEDULE 13GGridAI Technologies Corp.ENTOLIVE Ownership stake disclosure by Strategic EP, LLC
Strategic EP, LLC, filed by
ROUTINE4GridAI Technologies Corp.ENTOLIVE Edward Borkowski, insider filing for ENTO
Edward Borkowski, reporting
ROUTINE8-KGridAI Technologies Corp.ENTOLIVE ROUTINE4GridAI Technologies Corp.ENTOLIVE 2 insider filings
Manpreet Uppal, insider filing for ENTO
Show all 2
- 4Insider filing for ENTO
- 4Insider filing for ENTO
Manpreet Uppal, reporting
ROUTINE4GridAI Technologies Corp.ENTOLIVE 3 insider filings
Jason David Sawyer, insider filing for ENTO
Show all 3
- 4Insider filing for ENTO
- 4Insider filing for ENTO
- 3New insider at ENTO
Jason David Sawyer, reporting
ROUTINE8-KGridAI Technologies Corp.ENTOLIVE ROUTINE8-KGridAI Technologies Corp.ENTOLIVE NOTABLE10-QEntero Therapeutics, Inc.ENTOLIVE Entero Therapeutics, Inc. filed 10-Q
- Form Type: 10-Q
- Filing Date: 2025-11-19
ROUTINESCHEDULE 13GEntero Therapeutics, Inc.ENTOLIVE Renaissance Technologies LLC filed a Schedule 13G disclosing a 5.1% passive stake in Entero Therapeutics, Inc. (ENTO), a biopharmaceutical company.
RENAISSANCE TECHNOLOGIES LLC, filed by
ROUTINE8-KEntero Therapeutics, Inc.ENTOLIVE ROUTINE8-KEntero Therapeutics, Inc.ENTOLIVE